Gainers
- Entera Bio Ltd. (NASDAQ:ENTX) shares jumped 284% to $6.15 after the company disclosed positive topline EB613 Phase 2 biomarker data.
- Nova LifeStyle, Inc. (NASDAQ:NVFY) shares surged 112.1% to $5.09.
- PDS Biotechnology Corporation (NASDAQ:PDSB) jumped 64.6% to $6.24 after the company announced its COVID-19 vaccine consortium received a commitment from the MCTI to fund clinical development and commercialization of a Versamune-based COVID-19 vaccine with an award of up to $60 million.
- Timber Pharmaceuticals, Inc. (NASDAQ:TMBR) gained 37.1% to $2.77.
- Vir Biotechnology, Inc. (NASDAQ:VIR) rose 32.2% to $61.92. Vir Biotechnology and GSK disclosed that VIR-7831 reduced hospitalization and risk of death in early treatment of adults with COVID-19.
- Takung Art Co., Ltd. (NYSE:TKAT) jumped 31.8% to $3.599.
- RYB Education, Inc. (NYSE:RYB) surged 30.3% to 4.56.
- Longeveron Inc. (NASDAQ:LGVN) gained 30% to $9.34 after the company’s Lomecel-B was approved by the FDA for compassionate use for the treatment of child with hypoplastic left heart syndrome.
- Lizhi Inc. (NASDAQ:LIZI) jumped 25.3% to $9.90. Lizhi on Tuesday reported better-than-expected Q4 EPS and sales results.
- Siebert Financial Corp. (NASDAQ:SIEB) gained 25.2% to $5.39 following FY20 results. The company reported FY20 sales of $54.9 million, up from $28.6 million year over year.
- Contrafect Corporation (NASDAQ:CFRX) surged 25.2% to $6.36.
- Super League Gaming, Inc. (NASDAQ:SLGG) shares rose 25% to $6.93 after the company announced the acquisition of Mobcrush.
- OrganiGram Holdings Inc. (NASDAQ:OGI) gained 24.6% to $3.6012 after the company announced it formed a product development collaboration with BAT, which includes a strategic investment from BAT for 19.9% equity interest.
- Spark Networks SE (NYSE:LOV) surged 24.5% to $6.10.
- RLX Technology Inc. (NYSE:RLX) jumped 23.8% to $19.02.
- Innodata Inc. (NASDAQ:INOD) gained 23.3% to $7.34 following Q4 results.
- FinVolution Group (NYSE:FINV) rose 22.2% to $6.19 after the company reported Q4 results.
- Inspired Entertainment, Inc. (NASDAQ:INSE) gained 22.1% to $9.44 after the company reported better-than-expected Q4 EPS and sales results.
- UP Fintech Holding Limited (NASDAQ:TIGR) surged 21.5% to $23.36.
- Torchlight Energy Resources, Inc. (NASDAQ:TRCH) gained 21.4% to $2.745.
- IMAC Holdings, Inc. (NASDAQ:IMAC) shares jumped 21% to $2.54.
- Alimera Sciences, Inc. (NASDAQ:ALIM) gained 20.8% to $11.20.
- CooTek (Cayman) Inc. (NYSE:CTK) surged 20.2% to $3.1365.
- Qutoutiao Inc. (NASDAQ:QTT) gained 18.2% to $2.9080.
- Beam Global (NASDAQ:BEEM) shares jumped 17.9% to $45.56.
- Bumble Inc. (NASDAQ:BMBL) surged 17.6% to $73.97 following Q4 results.
- 22nd Century Group, Inc. (NYSE:XXII) gained 16.6% to $2.59 following Q4 results.
- Everspin Technologies, Inc. (NASDAQ:MRAM) surged 16.6% to $6.04.
- China HGS Real Estate Inc. (NASDAQ:HGSH) rose 16.1% to $2.09.
- GeoVax Labs, Inc. (NASDAQ:GOVX) rose 16% to $5.58. GeoVax, last week, announced filing of two additional COVID-related patent applications.
- Altimmune, Inc. (NASDAQ:ALT) gained 15.8% to $17.03.
- Rush Street Interactive, Inc. (NYSE:RSI) rose 13.7% to $18.81 following Q4 results.
- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) gained 10.3% to $3.3312 after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $5 per share.
- SCWorx Corp. (NASDAQ:WORX) shares rose 9% to $1.9190.
- ReneSola Ltd (NYSE:SOL) rose 8.7% to $14.99. Raymond James recently initiated coverage on the stock with an Outperform rating and announced a $14.5 price target.
- Emerson Radio Corp. (NYSE:MSN) rose 7.3% to $1.4048.
- Asana, Inc. (NYSE:ASAN) rose 6% to $33.80 after the company reported better-than-expected Q4 results and issued strong Q1 sales guidance.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- Just Energy Group Inc. (NYSE:JE) fell 23.5% to $1.99. The company announced that the Toronto Stock Exchange and the New York Stock Exchange have commenced delisting proceedings.
- Celsius Holdings, Inc. (NASDAQ:CELH) shares dipped 20.2% to $48.30 after the company reported Q4 results
- Enveric Biosciences, Inc. (NASDAQ:ENVB) fell 19% to $3.68. Enveric Biosciences shares jumped 55% on Wednesday in reaction to acquiring an exclusive, perpetual license for novel molecules from Diverse Biotech.
- MediciNova, Inc. (NASDAQ:MNOV) fell 19.1% to $7.07. MediciNova shares gained around 54% on Wednesday after the biopharmaceutical company announced a partnership with the Biomedical Advanced Research and Development Authority (BARDA) to repurpose MN-166 (ibudilast) as a potential medical countermeasure against lung damage induced by chlorine gas.
- AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares fell 19.6% to $12.29. The FDA has finally approved AVEO Pharmaceuticals’ tivozanib for advanced renal cell carcinoma, nine years after it first submitted its marketing application to the agency.
- Cemtrex, Inc. (NASDAQ:CETX) fell 18.4% to $2.09. Cemtrex shares jumped 53% on Wednesday with abnormally high session volume.
- Invacare Corporation (NYSE:IVC) dropped 18.1% to $8.16.
- Alto Ingredients, Inc. (NASDAQ:ALTO) fell 18% to $5.97 following Q4 results. The company posted a Q4 loss of $0.30 per share.
- Fossil Group, Inc. (NASDAQ:FOSL) tumbled 17.1% to $14.97 after the company reported Q4 results and named Sunil Doshi as CFO.
- Koss Corporation (NASDAQ:KOSS) fell 17% to $25.15 after surging around 69% on Wednesday.
- Amplify Energy Corp. (NYSE:AMPY) dropped 16.7% to $3.33 after the company reported worse-than-expected Q4 sales.
- New Concept Energy, Inc. (NYSE:GBR) fell 15.7% to $5.57 after gaining 45% on Wednesday.
- INVO Bioscience, Inc. (NASDAQ:INVO) fell 14.9% to $5.49 after dropping around 32% on Wednesday. The company’s stock jumped 202% on Tuesday after the company said it has amended its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals.
- Verb Technology Company, Inc. (NASDAQ:VERB) dropped 14.8% to $1.72 after the company announced a 9.375 million share common stock offering and priced it at $1.60 per share.
- NV5 Global, Inc. (NASDAQ:NVEE) dropped 14.5% to $91.56 after the company priced its underwritten public offering of common stock.
- Cloudera, Inc. (NYSE:CLDR) fell 13.2% to $12.78. Cloudera reported upbeat quarterly results, but issued weak FY22 guidance.
- Sumo Logic, Inc. (NASDAQ:SUMO) fell 13% to $22.41 after the company reported Q4 earnings results and issued Q1 & FY21 guidance. The company also announced it signed a definitive agreement to acquire DFLabs.
- Exela Technologies, Inc. (NASDAQ:XELA) fell 12.2% to $3.66 after declining 10% on Wednesday. Exela Technologies recently won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer.
- Red Violet, Inc. (NASDAQ:RDVT) dropped 11.7% to $18.89. Red Violet, on Wednesday, released Q4 results.
- Kadmon Holdings, Inc. (NASDAQ:KDMN) shares fell 10.7% to $4.39 after the company announced the FDA extended the review period for the New Drug Application for belumosudil for the treatment of chronic graft-versus-host disease.
- Savara Inc.(NASDAQ:SVRA) fell 10.3% to $1.6050 after reporting a common stock offering. The company in an 8-K reported it entered a Master Services Agreement with Parexel to provide contract services related to clinical trials conducted by the company.
- Clearside Biomedical, Inc. (NASDAQ:CLSD) fell 7.7% to $3.25 after the company reported worse-than-expected Q4 results.
- Oracle Corporation (NYSE:ORCL) fell 7% to $67.13 after the company reported Q3 earnings results.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.